Mcsp torfp no. NIH-ninds-21-01: florio (anagin) - base EC (stroke)
Ended Awarded Last action
- Contract number
- 75N95021F00022
- Awardee
-
Curia Global Inc. UEI ELCNZCS8GEA3
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,420,025
Award facts
- Opportunity
-
- NIHNINDS2101 Solicitation number
- Contract value 100% obligated
- $3,420,024.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Institute of Neurological Disorders and Stroke National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Albany, NY 12212, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $1,476,441 | |
| Exercise an Option | $1,311,264 | |
| Original award | $632,319 |
About this award
The Department of Health and Human Services National Institutes of Health National Institute of Neurological Disorders and Stroke awarded a $3.42 million cost-plus-fixed-fee delivery order contract to Curia Global Inc., doing business as Amri, to support the Medicinal Chemistry Support Program for Therapeutic Development. Under the contract, Amri will provide services for the MCSP TORFP NO. NIH-NINDS-21-01 solicitation to support the FLORIO (ANAGIN) program focused on stroke. The contract has a period of performance from January 2021 through December 2024 to support the National Institute of Neurological Disorders and Stroke's research efforts through the Medicinal Chemistry Support Program.
Quick answers
Who was awarded contract 75N95021F00022?
75N95021F00022 was awarded to Curia Global Inc. by National Institute on Drug Abuse (National Institutes of Health) on January 26, 2021.
How much is contract 75N95021F00022 worth?
The government has obligated $3,420,025 on 75N95021F00022.
Which agency awarded contract 75N95021F00022?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95021F00022, with funding from National Institute of Neurological Disorders and Stroke (National Institutes of Health).
Is contract 75N95021F00022 an order under another contract?
Yes. 75N95021F00022 is a delivery order under HHSN271201800001I, an indefinite delivery contract.
Was contract 75N95021F00022 competed?
The extent of competition for 75N95021F00022 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award